Sosne et al
Section 11101(b) of the IRA amended section 1833(a)(1) of the Act by adding a new subparagraph (EE), which requires that if the payment amount under section 1847A(i)(3)(A)(ii)(I) of the Act or, in the case of a selected drug described under section 1192(c) of the Act, the payment amount described in section 1847A(b)(1)(B) of the Act, for that drug exceeds the inflation-adjusted payment amount for a Part B rebatable drug, the Part B payment amount would, subject to the Part B deductible and sequestration, equal the difference between such payment amount and the inflation-adjusted coinsurance amount
Sources scientifiques Pickart L, Vasquez-Soltero JM, Margolina A
Gold particle-coupled secondary antibodies were diluted at a ratio of 1:50, followed by post-staining with aqueous uranyl acetate and lead citrate
Surface biotinylation assay To evaluate the surface expression of mutant receptors we carried out surface biotinylation assay
Label every vial immediately upon reconstitution with both the mix date and the discard date (28 days forward) using a permanent marker directly on the vial